The teen is the first student from Levittown's General Douglas MacArthur High School to be named a finalist in the ...

This was the stock's third consecutive day of losses.

This was the stock's second consecutive day of losses.

NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...

Regeneron’s (REGN) treatment of lipodystrophy, mibavademab, was granted FDA orphan designation, according to a post on the agency’s website. See what stocks are receiving Strong Buy ratings ...

[Applied Science] shows how you can add an array of tiny LEDs and some compute power to produce high-resolution images — higher than you can get with the microscope on its own. The idea is to ...

Long Island's six Regeneron Science Talent Search finalists are not yet out of high school and already ... “He has this independence that's the quality that all scientists — real scientists ...

It has been about a month since the last earnings report for Regeneron (REGN). Shares have lost about 4.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

Regeneron Pharmaceuticals (NASDAQ ... The main reason is the extremely high competition in the PD-1/PD-L1 checkpoint inhibitors market, which includes Merck's Keytruda, Bristol-Myers Squibb's ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...